Venture Capital

MAPS and Columbia University launch a landmark study into MDMA-assisted couples therapy, seeking to turn decades of underground practice into a safe future.

Beyond retail, Pacsun is investing in the next generation of musicians, using co-creation and strategic partnerships to build authentic cultural relevance.

Madison Square Garden and Infosys deepen their tech partnership, rebranding the iconic theater and promising new AI-driven experiences for Knicks and Rangers fans.

The iconic F1 team is integrating Anthropic's Claude AI to navigate 2026's massive rule changes, aiming to outthink rivals and return to the top.

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Madison Square Garden's theater is renamed as part of an expanded deal, leveraging AI to redefine the fan experience for sports and entertainment.

Following a federal probe into a Waymo robotaxi hitting a child, the Teamsters union calls for an indefinite ban, escalating the battle over AV safety and jobs.

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.

Forrester recognizes Kaltura for its AI, signaling a market shift toward hyper-personalized events, immersive avatars, and long-term content value.

India’s Polymatech signals a major U.S. market offensive, appointing a seasoned leader to drive growth and explore domestic manufacturing possibilities.

Bengaluru's JJG Aero has secured $30M to scale production, positioning India as a key solution to the aerospace industry's critical supply shortages.

The oil & gas operator is one step from a NYSE listing, promising a 13.5% dividend yield and a major consolidation play in the mature assets market.

The long-duration energy storage firm closed a key offering, signaling investor confidence in its iron flow technology despite a challenging year for its stock.

Tevogen Bio's stock surged on news of a potential special dividend, but a closer look reveals a risky promise from a pre-revenue firm facing major hurdles.

With key proposals at risk due to low voter turnout, Plug Power faces a forced reverse stock split, creating a high-stakes showdown with its investors.

Greenland Resources' Malmbjerg project aims to slash EU reliance on China for key minerals, backed by major financing and a green-tech approach.

The Non-GMO Project's grant program helps BIPOC food entrepreneurs overcome barriers, gain market access, and reshape the natural products industry.